Article Versions Notes

Deblanc C, Quéguiner S, Gorin S, Chastagner A, Hervé S, Paboeuf F, Simon G. Evaluation of the Pathogenicity and the Escape from Vaccine Protection of a New Antigenic Variant Derived from the European Human-Like Reassortant Swine H1N2 Influenza Virus. Viruses. 2020; 12(10):1155. https://doi.org/10.3390/v12101155

Deblanc, Céline, Stéphane Quéguiner, Stéphane Gorin, Amélie Chastagner, Séverine Hervé, Frédéric Paboeuf, and Gaëlle Simon. 2020. "Evaluation of the Pathogenicity and the Escape from Vaccine Protection of a New Antigenic Variant Derived from the European Human-Like Reassortant Swine H1N2 Influenza Virus" Viruses 12, no. 10: 1155. https://doi.org/10.3390/v12101155

Deblanc, C., Quéguiner, S., Gorin, S., Chastagner, A., Hervé, S., Paboeuf, F., & Simon, G. (2020). Evaluation of the Pathogenicity and the Escape from Vaccine Protection of a New Antigenic Variant Derived from the European Human-Like Reassortant Swine H1N2 Influenza Virus. Viruses, 12(10), 1155. https://doi.org/10.3390/v12101155